StockpollyBeta
Get App
Delisting riskPopularity #5,362
RVPH · NASDAQ · Biotechnology

Reviva Pharmaceuticals (RVPH)

Develops brilaroxazine-led therapies for CNS, inflammatory, and cardiometabolic diseases.

$0.4800
vs last close−0.05 (−9.09%)

Something off on this page? Send us feedback.

13F · 13D/G · Form 4

Institutions0.06%7.7K shares
5 holders · as of Jun 30, 2026
Strategic holders11.88%1.56M shares
2 holders · as of May 14, 2026
Other88.06%11.55M shares
remainder

13.11M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

13F · 13D/G · Form 4

HolderStakeSharesDate
Integrated Core Strategies (US) LLCStrategic
6.06%793,952filed Mar 30, 2026
Barclays PLCStrategic
5.82%763,579filed May 14, 2026
UBS Group AGInstitution
5.69%746,095filed May 7, 2026
Emc Capital ManagementInstitution
0.05%6,696as of Jun 30, 2026
TD Waterhouse Canada Inc.Institution
0.00%625as of Jun 30, 2026
Purpose Unlimited Inc.Institution
0.00%405as of Jun 30, 2026
Miller Global Investments, LLCInstitution
0.00%1as of Jun 30, 2026
Mosley Wealth ManagementInstitution
0.00%1as of Jun 30, 2026
Highbridge Capital Management, LLCStrategic
—9.90% of class, as filed—filed Aug 14, 2025
K2 GenPar L.P.Insider
—4.53% of class, as filed—filed Feb 13, 2019
Mizuho Financial Group, Inc.Institution
—7.70% of class, as filed—filed Feb 14, 2020
Notes).Insider
—7.38% of class, as filed—filed Apr 2, 2019
Steven BoydInsider
—6.32% of class, as filed—filed Feb 14, 2024
Tenzing LLC1Strategicdirector, 10 percent owner
0.81%106,088filed Dec 28, 2020
Parag Saxena2,3Insiderdirector, 10 percent owner, officer: Chairman of the Board
0.73%96,213filed Sep 4, 2018
Mizuho Securities USA LLC4Strategic10 percent owner
0.29%38,338filed May 15, 2020
Prabhu Narayan5Insiderofficer: Chief Financial Officer
0.04%5,000filed Oct 3, 2022
Vedanta Partners, LLC6Strategic10 percent owner
0.04%4,977filed Jun 3, 2021
Purav Patel7Insiderdirector
0.02%2,177filed Nov 21, 2022
Laxminarayan Bhat8,9Insiderdirector, 10 percent owner, officer: President and CEO
0.00%269filed Dec 18, 2020
Marc Cantillon8Insiderofficer: Chief Medical Officer
0.00%269filed Dec 18, 2020
Glazer Capital, LLC10Strategic10 percent owner
0.00%0filed Dec 10, 2020
Rahul Nayar2,11Insiderdirector, 10 percent owner, officer: Chief Executive Officer
0.00%0filed Sep 4, 2018
  1. Last filed Dec 28, 2020; leaving the company requires no filing. Not in the bar.
  2. Last filed Sep 4, 2018; leaving the company requires no filing. Not in the bar.
  3. Reported at 2.80% on Mar 24, 2026, under the 5% line, so no further filing is required.
  4. Last filed May 15, 2020; leaving the company requires no filing. Not in the bar.
  5. Last filed Oct 3, 2022; leaving the company requires no filing. Not in the bar.
  6. Last filed Jun 3, 2021; leaving the company requires no filing. Not in the bar.
  7. Last filed Nov 21, 2022; leaving the company requires no filing. Not in the bar.
  8. Last filed Dec 18, 2020; leaving the company requires no filing. Not in the bar.
  9. Reported at 3.80% on Sep 24, 2025, under the 5% line, so no further filing is required.
  10. Last filed Dec 10, 2020; leaving the company requires no filing. Not in the bar.
  11. Rahul Nayar reports a block also reported by Parag Saxena; it is counted once, under Parag Saxena.

13F, as of Jun 30, 2026

5 holders · 7.7K shares · 3 new positions · 3 increased · 0 reduced · 34 closed

HolderShares% outstandingChg q/qFiled
Emc Capital Management6.7K0.05%+6.7KnewJul 29, 2026
TD Waterhouse Canada Inc.6250.00%0Jul 27, 2026
Purpose Unlimited Inc.4050.00%0Aug 13, 2026
Mosley Wealth Management10.00%+1newJul 23, 2026
Miller Global Investments, LLC10.00%+1newJul 1, 2026

13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Highbridge Capital Management, LLC9.90%13GAug 14, 2025
Integrated Core Strategies (US) LLC6.20%794.0K13GMar 30, 2026
Barclays PLC5.96%763.6K13GMay 14, 2026
UBS Group AG5.80%746.1K13GMay 7, 2026
Parag Saxenaincl. Vedanta Partners, LLC5.20%13DDec 22, 2025

Form 4

Latest trades

No open-market trades in the last 12 months.

House and Senate disclosures

Not reported.